FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Approves Genentechs Itovebi Breast Cancer Drug

FDA approves Genentechs Itovebi to be used with two other drugs to treat some breast cancers identified through a diagnostic test.

latest-news-card-1
Human Drugs

Implantable Bladder Stimulator Study Approved

FDA approves an IDE for Iota Biosciences to conduct a feasibility study of its investigational implantable device designed to deliver electrical stimu...

latest-news-card-1
Human Drugs

Part 11 Final Guide has Broader Applicability: Attorneys

Attorneys at Hogan Lovells say (XXX DELETE s XXX)that a final guidance on electronic records and systems used in clinical trials includes a broader sc...

latest-news-card-1
Human Drugs

Teva Pays $450 Million to Settle Kickback Cases

Teva Pharmaceuticals agrees to pay $450 million to resolve two civil cases that allege the company violated the Anti-Kickback Statute and the False Cl...

latest-news-card-1
Human Drugs

Nanchang Anobri FDA-483 Released

FDA releases the form FDA-483 with 12 observations from a 2023 inspection at Chinas Nanchang Anobri drug manufacturing facility.

latest-news-card-1
Medical Devices

Zyno Medical Recalls Z-800 Infusion Devices

Zyno Medical recalls (Class 1 device correction) various models of its Z-800 Infusion System due to a defect in the air in-line software.

latest-news-card-1
Human Drugs

Do More to Prevent DSCSA Disruptions: Congress

Some 21 House Democrats and Republicans ask FDA to take more steps to prevent drug shortages as the Drug Supply Chain Security Act hits its 11/27 impl...

latest-news-card-1
Human Drugs

Neuvivo Files NDA for Lou Gehrigs Therapy

Neuvivo files an NDA for NP001 (sodium chlorite infusion) for treating amyotrophic lateral sclerosis (also known as Lou Gehrigs disease).

latest-news-card-1
Human Drugs

FDA New Alternative Methods Office Needed: Report

An FDA Science Advisory Board subcommittee calls on the agency to create a centralized office to coordinate work on New Alternative Methods.

latest-news-card-1
Medical Devices

IDE OKd for Robotic Prostate Cancer Surgery

FDA approves a Procept BioRobotics IDE for a clinical trial comparing its Aquablation therapy to radical prostatectomy in men with prostate cancer.